HEALTHTHE HILL
Moderna gets $50M investment for Ebola vaccine candidate
The Coalition for Epidemic Preparedness Innovations (CEPI) will invest $50 million to develop and test Moderna's vaccine against the Bundibugyo strain of Ebola. The funding may also support manufacturing and later-stage trials if early data are positive.
Mentioned
Related Signal
Adjacent reporting
- STAT+: Eli Lilly to buy three small vaccine developers
- Government 'prepare for potential bird flu outbreak' as they invest millions into vaccine trials
- A New Hantavirus Vaccine Is in the Works
- Healthy Returns: Eli Lilly makes a new push into vaccines – here’s what to know
- STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and more
- Oxford scientists developing new vaccine to tackle Ebola outbreak within months